Health Herald Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Herald Grenada.

Press releases published on July 30, 2026

8 hours ago

Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology

Indeterminate GlobeNewswire

8 hours ago

Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

8 hours ago

HUTCHMED Reports 2026 Interim Results

Indeterminate GlobeNewswire

8 hours ago

Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

8 hours ago

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors

Indeterminate GlobeNewswire

9 hours ago

Agios Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

9 hours ago

Regeneron Reports Second Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

9 hours ago

Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales

Indeterminate GlobeNewswire

9 hours ago

Amneal Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

10 hours ago

Questex’s Fierce Pharma announces launch of Fierce Pharma Week Europe in Basel, Switzerland in June 2027

Indeterminate GlobeNewswire

12 hours ago

Actimed Therapeutics Strengthens Board with Appointment of Dr. Anders Ullman

Indeterminate GlobeNewswire

12 hours ago

Relation unveils MORGAN, the next-generation model of cellular biology

Indeterminate GlobeNewswire

12 hours ago

Relation Announces Expanded Collaboration with GSK

Indeterminate GlobeNewswire

13 hours ago

AB2 Bio receives $30 million from Nippon Shinyaku for exclusive U.S. commercialization rights to Tadekinig Alfa

Indeterminate GlobeNewswire

13 hours ago

Curium advances plans for second investment in Romania to expand access to advanced nuclear medicine

Indeterminate GlobeNewswire

13 hours ago

Sugar Reset Drops Label Guide: What the Supplement Facts Panel, Serving Directions, and Safety Statements Disclose for 2026

Indeterminate GlobeNewswire

14 hours ago

Press Release: Q2 2026: double-digit sales growth and strong business EPS growth; 2026 guidance upgraded

Indeterminate GlobeNewswire

14 hours ago

Communiqué de presse : T2 2026 : croissance à deux chiffres du chiffre d’affaires et forte progression du BNPA ; révision à la hausse des perspectives 2026

Indeterminate GlobeNewswire

14 hours ago

Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance

Indeterminate GlobeNewswire

14 hours ago

Ipsen réalise d’excellents résultats au premier semestre 2026 et relève ses objectifs financiers annuels

Indeterminate GlobeNewswire